

Fundamental dimension Equity attribute | GFIPeer $34.58▼-1.59% Cap $30.81BP/E 6.9x QuantScore77/100 | AEMLeader $187.61▼-1.01% Cap $95.00BP/E 16.1x QuantScore81/100 | AGIPeer $29.94▼-1.19% Cap $12.53BP/E 10.8x QuantScore66/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
48/100 |
70/100 |
16/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 87/100 | 68/100 |
Health Piotroski, Altman Z, leverage & liquidity | 87/100 | 100/100 | 88/100 |
Growth Revenue / earnings growth & margins | 93/100 | 94/100 | 94/100 |
Sentiment Analyst ratings, targets & revisions | 58/100 | 54/100 | 63/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 6.9x | 16.1x | 10.8x |
Forward P/E (next FY) | 7.4x | 16.2x | 13.9x |
EV / EBITDA (TTM) | 4.3x | 8.9x | 6.9x |
Price / Sales | 2.7x | 6.6x | 5.7x |
Price / Free Cash Flow | 6.8x | 21.1x | 39.7x |
PEG ratio | 0.07 | 0.17 | 0.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 9 / 9 | 8 / 9 |
Altman Z-Score | 5.92 (Safe) | 7.83 (Safe) | 5.24 (Safe) |
Total debt / equity | 0.29 | 0.01 | 0.05 |
Quick ratio | 1.9x | 2.0x | 1.4x |
Interest coverage | 38.1x | 115.9x | 669.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +68.8% | +43.7% | +34.6% |
Net income growth YoY | +187.4% | +135.4% | +212.8% |
Gross margin (TTM) | 57.3% | 62.5% | 60.1% |
Operating margin (FY) | 48.4% | 53.1% | 44.5% |
FCF margin (FY) | 35.6% | 35.8% | 15.0% |
5. Trailing price performancePrice change over period |
1M return | -13.3% | -6.0% | -12.2% |
3M return | +5.8% | +37.0% | +1.2% |
6M return | -24.4% | -14.8% | -33.7% |
Year to date | -20.8% | +10.7% | -22.4% |
1Y return | -14.2% | +5.1% | -5.1% |
3Y return | +153.8% | +278.1% | +131.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $49.26 +42.4% upside | $196.32 +4.6% upside | $-6.03 -120.1% premium |
Wall Street consensus target | $49.06 +41.9% · range $38.00–$57.25 | $216.17 +15.2% · range $170.00–$260.00 | $42.00 +40.3% · range $42.00–$42.00 |
Consensus stance | 44% Buy56% Hold0% Sell | 68% Buy29% Hold3% Sell | 54% Buy46% Hold0% Sell |